Clinical Trial Update: Ultrasound Guided Octreotide LAR Injection in Acromegaly [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on ultrasound-guided Octreotide LAR injections for acromegaly; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly

Drugs mentioned

• Octreotide LAR (octreotide long-acting release)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Acromegaly | Phase 4 | Status: COMPLETED | Results posted: 2018-09-11